Intuitive Surgical, Inc. (0R29.L)
USD 532.14
(2.67%)
USD 532.14
(2.67%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.79 Billion USD | 35.98% |
| 2022 | 1.32 Billion USD | -22.43% |
| 2021 | 1.7 Billion USD | 60.72% |
| 2020 | 1.06 Billion USD | -23.11% |
| 2019 | 1.37 Billion USD | 22.29% |
| 2018 | 1.12 Billion USD | 70.89% |
| 2017 | 660 Million USD | -10.31% |
| 2016 | 735.9 Million USD | 24.98% |
| 2015 | 588.8 Million USD | 40.59% |
| 2014 | 418.8 Million USD | -37.59% |
| 2013 | 671 Million USD | 2.19% |
| 2012 | 656.6 Million USD | 32.62% |
| 2011 | 495.1 Million USD | 29.68% |
| 2010 | 381.8 Million USD | 64.14% |
| 2009 | 232.6 Million USD | 13.85% |
| 2008 | 204.31 Million USD | 41.36% |
| 2007 | 144.53 Million USD | 100.62% |
| 2006 | 72.04 Million USD | -23.47% |
| 2005 | 94.13 Million USD | 300.95% |
| 2004 | 23.47 Million USD | 343.98% |
| 2003 | -9.62 Million USD | 47.76% |
| 2002 | -18.42 Million USD | -10.31% |
| 2001 | -16.7 Million USD | 9.84% |
| 2000 | -18.52 Million USD | -0.59% |
| 1999 | -18.41 Million USD | 37.46% |
| 1998 | -29.44 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 565.1 Million USD | 7.25% |
| 2024 Q1 | 544.9 Million USD | -10.11% |
| 2024 Q2 | 526.9 Million USD | -3.3% |
| 2023 Q3 | 415.7 Million USD | -1.21% |
| 2023 Q2 | 420.8 Million USD | 18.44% |
| 2023 Q1 | 355.3 Million USD | 9.36% |
| 2023 FY | 1.79 Billion USD | 35.98% |
| 2023 Q4 | 606.2 Million USD | 45.83% |
| 2022 Q3 | 324 Million USD | 5.26% |
| 2022 Q1 | 365.6 Million USD | -3.94% |
| 2022 FY | 1.32 Billion USD | -22.43% |
| 2022 Q4 | 324.9 Million USD | 0.28% |
| 2022 Q2 | 307.8 Million USD | -15.81% |
| 2021 FY | 1.7 Billion USD | 60.72% |
| 2021 Q2 | 517.2 Million USD | 21.32% |
| 2021 Q1 | 426.3 Million USD | 16.73% |
| 2021 Q4 | 380.6 Million USD | 0.03% |
| 2021 Q3 | 380.5 Million USD | -26.43% |
| 2020 Q3 | 313.9 Million USD | 361.62% |
| 2020 FY | 1.06 Billion USD | -23.11% |
| 2020 Q1 | 313.5 Million USD | -12.36% |
| 2020 Q2 | 68 Million USD | -78.31% |
| 2020 Q4 | 365.2 Million USD | 16.34% |
| 2019 FY | 1.37 Billion USD | 22.29% |
| 2019 Q4 | 357.7 Million USD | -9.85% |
| 2019 Q3 | 396.8 Million USD | 24.66% |
| 2019 Q2 | 318.3 Million USD | 3.85% |
| 2019 Q1 | 306.5 Million USD | 4.79% |
| 2018 Q2 | 255.3 Million USD | -11.23% |
| 2018 Q4 | 292.5 Million USD | 0.0% |
| 2018 FY | 1.12 Billion USD | 70.89% |
| 2018 Q1 | 287.6 Million USD | 841.24% |
| 2018 Q3 | 292.5 Million USD | 14.57% |
| 2017 Q2 | 221.5 Million USD | 23.19% |
| 2017 Q1 | 179.8 Million USD | -11.86% |
| 2017 FY | 660 Million USD | -10.31% |
| 2017 Q4 | -38.8 Million USD | -113.04% |
| 2017 Q3 | 297.5 Million USD | 34.31% |
| 2016 Q4 | 204 Million USD | -3.32% |
| 2016 Q2 | 184.5 Million USD | 35.26% |
| 2016 Q3 | 211 Million USD | 14.36% |
| 2016 FY | 735.9 Million USD | 24.98% |
| 2016 Q1 | 136.4 Million USD | -28.21% |
| 2015 Q1 | 97 Million USD | -33.92% |
| 2015 Q2 | 134.5 Million USD | 38.66% |
| 2015 Q3 | 167.3 Million USD | 24.39% |
| 2015 FY | 588.8 Million USD | 40.59% |
| 2015 Q4 | 190 Million USD | 13.57% |
| 2014 Q4 | 146.8 Million USD | 18.67% |
| 2014 Q1 | 44.3 Million USD | -73.35% |
| 2014 FY | 418.8 Million USD | -37.59% |
| 2014 Q2 | 104 Million USD | 134.76% |
| 2014 Q3 | 123.7 Million USD | 18.94% |
| 2013 Q4 | 166.2 Million USD | 5.99% |
| 2013 Q2 | 159.1 Million USD | -15.78% |
| 2013 Q1 | 188.9 Million USD | 8.0% |
| 2013 FY | 671 Million USD | 2.19% |
| 2013 Q3 | 156.8 Million USD | -1.45% |
| 2012 Q1 | 143.5 Million USD | -5.09% |
| 2012 FY | 656.6 Million USD | 32.62% |
| 2012 Q4 | 174.9 Million USD | -4.58% |
| 2012 Q3 | 183.3 Million USD | 18.33% |
| 2012 Q2 | 154.9 Million USD | 7.94% |
| 2011 Q4 | 151.2 Million USD | 23.53% |
| 2011 Q3 | 122.4 Million USD | 4.26% |
| 2011 FY | 495.1 Million USD | 29.68% |
| 2011 Q2 | 117.4 Million USD | 12.78% |
| 2011 Q1 | 104.1 Million USD | -14.11% |
| 2010 Q2 | 88.7 Million USD | 3.99% |
| 2010 Q4 | 121.2 Million USD | 39.95% |
| 2010 Q3 | 86.6 Million USD | -2.37% |
| 2010 Q1 | 85.3 Million USD | 9.99% |
| 2010 FY | 381.8 Million USD | 64.14% |
| 2009 Q1 | 28.14 Million USD | -44.56% |
| 2009 FY | 232.6 Million USD | 13.85% |
| 2009 Q4 | 77.55 Million USD | 20.19% |
| 2009 Q3 | 64.52 Million USD | 3.42% |
| 2009 Q2 | 62.38 Million USD | 121.69% |
| 2008 Q4 | 50.75 Million USD | -11.87% |
| 2008 FY | 204.31 Million USD | 41.36% |
| 2008 Q3 | 57.59 Million USD | 12.53% |
| 2008 Q2 | 51.18 Million USD | 14.29% |
| 2008 Q1 | 44.78 Million USD | -8.89% |
| 2007 Q3 | 40.91 Million USD | 33.45% |
| 2007 Q2 | 30.66 Million USD | 28.83% |
| 2007 Q1 | 23.8 Million USD | 0.68% |
| 2007 FY | 144.53 Million USD | 100.62% |
| 2007 Q4 | 49.15 Million USD | 20.12% |
| 2006 Q3 | 17.26 Million USD | 3.48% |
| 2006 FY | 72.04 Million USD | -23.47% |
| 2006 Q2 | 16.68 Million USD | 15.38% |
| 2006 Q1 | 14.45 Million USD | -70.81% |
| 2006 Q4 | 23.64 Million USD | 36.95% |
| 2005 Q2 | 14.78 Million USD | 62.39% |
| 2005 Q3 | 20.72 Million USD | 40.15% |
| 2005 Q4 | 49.52 Million USD | 139.03% |
| 2005 Q1 | 9.1 Million USD | -22.07% |
| 2005 FY | 94.13 Million USD | 300.95% |
| 2004 Q4 | 11.68 Million USD | 91.1% |
| 2004 Q1 | 853 Thousand USD | 117.57% |
| 2004 Q2 | 4.83 Million USD | 466.24% |
| 2004 Q3 | 6.11 Million USD | 26.56% |
| 2004 FY | 23.47 Million USD | 343.98% |
| 2003 Q2 | 878 Thousand USD | 138.29% |
| 2003 FY | -9.62 Million USD | 47.76% |
| 2003 Q1 | -2.29 Million USD | 11.81% |
| 2003 Q4 | -4.85 Million USD | -44.8% |
| 2003 Q3 | -3.35 Million USD | -481.89% |
| 2002 Q3 | -6.46 Million USD | -72.83% |
| 2002 Q4 | -2.6 Million USD | 59.78% |
| 2002 Q2 | -3.74 Million USD | 33.42% |
| 2002 Q1 | -5.61 Million USD | -32.1% |
| 2002 FY | -18.42 Million USD | -10.31% |
| 2001 Q4 | -4.25 Million USD | 11.38% |
| 2001 Q2 | -4.24 Million USD | -24.57% |
| 2001 Q1 | -3.4 Million USD | 31.6% |
| 2001 FY | -16.7 Million USD | 9.84% |
| 2001 Q3 | -4.79 Million USD | -13.05% |
| 2000 Q4 | -4.98 Million USD | -23.91% |
| 2000 Q3 | -4.02 Million USD | 10.47% |
| 2000 FY | -18.52 Million USD | -0.59% |
| 2000 Q2 | -4.49 Million USD | 10.77% |
| 2000 Q1 | -5.03 Million USD | 0.0% |
| 1999 FY | -18.41 Million USD | 37.46% |
| 1998 FY | -29.44 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 1413.511% |
| Accuray Incorporated | -15.54 Million USD | 11666.42% |
| Align Technology, Inc. | 445.05 Million USD | -303.997% |
| Elevance Health Inc. | 5.98 Billion USD | 69.968% |
| AxoGen, Inc. | -21.71 Million USD | 8379.61% |
| Boston Scientific Corporation | 1.59 Billion USD | -12.869% |
| CVS Health Corporation | 8.34 Billion USD | 78.452% |
| Cardinal Health, Inc. | 852 Million USD | -111.033% |
| Centene Corporation | 2.7 Billion USD | 33.457% |
| DaVita Inc. | 691.53 Million USD | -160.001% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 65.7% |
| Hologic, Inc. | 789.5 Million USD | -127.739% |
| Humana Inc. | 2.48 Billion USD | 27.762% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -112.77% |
| Laboratory Corporation of America Holdings | 418 Million USD | -330.144% |
| Masimo Corporation | 81.5 Million USD | -2106.135% |
| McKesson Corporation | 3 Billion USD | 40.107% |
| Patterson Companies, Inc. | 185.93 Million USD | -867.025% |
| Quest Diagnostics Incorporated | 854 Million USD | -110.539% |
| ResMed Inc. | 1.02 Billion USD | -76.11% |
| Henry Schein, Inc. | 416 Million USD | -332.212% |
| Teladoc Health, Inc. | -220.36 Million USD | 915.908% |
| Universal Health Services, Inc. | 717.79 Million USD | -150.489% |
| Veeva Systems Inc. | 525.7 Million USD | -242.017% |
| Baxter International Inc. | 2.65 Billion USD | 32.304% |
| Becton, Dickinson and Company | 1.48 Billion USD | -21.159% |
| Danaher Corporation | 4.2 Billion USD | 57.19% |
| Stryker Corporation | 3.16 Billion USD | 43.191% |
| Medtronic plc | 3.67 Billion USD | 51.088% |